Healthcare & Life Sciences
Tacit Therapeutics
United Stateswww.linkedin.com/company/tacit-therapeutics
aliveseries-a
series-a
Stage
1
Investors
About
Tacit Therapeutics develops RNA-targeting therapies using a proprietary trans-splicing platform to repair mutated genes and treat inherited diseases such as Huntington's disease and Dravet syndrome.
Explore Tacit Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.